A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis
Latest Information Update: 06 Oct 2025
At a glance
- Drugs KAN 004 (Primary)
- Indications Colitis; Diarrhoea
- Focus Adverse reactions
Most Recent Events
- 06 Oct 2025 New trial record